VE202

BIOLOGICAL2 trials

Sponsors

Vedanta Biosciences Inc., Vedanta Biosciences, Inc.

Conditions

Colitis, UlcerativeMild-to-moderate ulcerative colitisUlcerative Colitis

Phase 2

VE202 in Patients With Mild-to-Moderate Ulcerative Colitis

TerminatedNCT05370885

Vedanta Biosciences, Inc.Colitis, Ulcerative, Ulcerative Colitis

Start: 2023-05-08End: 2025-08-29Updated: 2025-12-17

Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of VE202 in Patients with Mild-to-Moderate Ulcerative Colitis

CompletedCTIS2024-512558-40-00

Vedanta Biosciences Inc.Mild-to-moderate ulcerative colitis

Start: 2023-05-11End: 2025-08-11Target: 74Updated: 2025-07-28